English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1157]
News [2523]
Articles [155]
Editorials [8]
Conferences [103]
elearning [18]
Prostate cancer test may lead to harmful overdiagnosis in black men
Prostate cancer test may lead to harmful overdiagnosis in black men
Immunotherapy combination may benefit patients with transplanted kidneys and advanced skin cancers
Immunotherapy combination may benefit patients with transplanted kidneys and advanced skin cancers
Prognostic model development and molecular subtypes identification in bladder urothelial cancer
Prognostic model development and molecular subtypes identification in bladder urothelial cancer
Families of men with fertility problems show distinct patterns of increased risk for several types of cancer
Families of men with fertility problems show distinct patterns of increased risk for several types of cancer
Uncovering insights about prostate cancer risk and genetic ancestry
Uncovering insights about prostate cancer risk and genetic ancestry
New tumour spatial mapping tool will help clinicians assess aggressiveness of cancer and personalise treatment
New tumour spatial mapping tool will help clinicians assess aggressiveness of cancer and personalise treatment
For Black patients, 'representation matters' in evaluating prostate cancer websites
For Black patients, 'representation matters' in evaluating prostate cancer websites
First MYC inhibitor to demonstrate safety and anti-tumour activity in a phase I first-in-human clinical trial
First MYC inhibitor to demonstrate safety and anti-tumour activity in a phase I first-in-human clinical trial
New therapeutic strategy for metastatic prostate cancer patients resistant to standard treatment
New therapeutic strategy for metastatic prostate cancer patients resistant to standard treatment
Some tumors ‘grow bad’: Why a dangerous subtype of Wilms tumour is so resistant to chemotherapy
Some tumors ‘grow bad’: Why a dangerous subtype of Wilms tumour is so resistant to chemotherapy
<1...2122232425...253>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top